The week in health tech, explained in plain English.Get the free newsletter →
October 27, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Payers Keep Betting on Services, but Discipline Rules Now

The nation's biggest health insurers have spent years expanding beyond coverage into care delivery, pharmacy, and services, and the investments keep mounting, according to Becker's Hospital Review. The strategy has steadily blurred the line between paying for care and providing it, turning traditional payers into diversified healthcare operators.

But the mood is shifting from expansion at all costs to discipline. Becker's reports that while some services bets are paying off and positioning companies as more than insurers, others are being pared back. Cigna is among the companies reassessing its portfolio, a signal that scale alone no longer justifies every acquisition or business line.

In practice, that means insurers are weighing which assets genuinely improve margins and member outcomes versus which drain capital. For hospitals, providers, and investors, the takeaway is that payer diversification is maturing. The land grab phase is giving way to harder questions about what actually works, and companies are increasingly willing to retreat from bets that do not.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.